BriaCell publishes investor presentation on Bria-IMT immunotherapy program for metastatic breast cancerPUBT·Jul 21 at 10:28 AMBCTXW0.00%BCTXZ+0.30%
Is CRA International (CRAI) Quietly Redefining Its Oncology Consulting Edge With The Bria-IMT Mandate?Simplywall·Jul 16 at 12:08 PMCRAI+1.46%BCTXW0.00%
BriaCell opens first Canadian Phase 3 trial site at Sunnybrook’s Odette Cancer Centre in TorontoPUBT·Jul 16 at 06:31 AMBCTX-3.76%BCTXW0.00%
BriaCell signs manufacturing deal with FUJIFILM Biotechnologies for Bria-IMT Phase 3 supplyPUBT·Jul 15 at 06:30 AMBCTX-3.76%BCTXW0.00%
BriaCell subsidiary BriaPro reports $1.32M assets, $299,950 cash after sCD80 license acquisitionTradingView·Jun 26 at 03:13 PMBCTXZ+0.30%BCTX-3.76%
BriaCell signs MoU with Uneedle on microneedle delivery for Bria-IMT breast cancer therapyPUBT·Jun 25 at 06:30 AMBCTXW0.00%BCTXZ+0.30%
BriaCell publishes investor presentation on Bria-IMT pivotal Phase 3 metastatic breast cancer programPUBT·Jun 18 at 09:59 PMBCTXZ+0.30%BCTXW0.00%
BriaCell Therapeutics 3Q FY2026: Net loss $(7.16M), EPS $(0.99) — 10-Q SummaryTradingView·Jun 9 at 03:11 PMBCTXW0.00%BCTX-3.76%
North American Morning Briefing: Tech Rally Rolls On as Markets Look Past Fresh U.S.-Iran Strikes -2-MorningStar·Jun 1 at 05:30 AMBCTXW0.00%BBY+1.18%
